Literature DB >> 12180230

Accuracy of frozen section examination of testicular tumors of uncertain origin.

Achim Elert1, Peter Olbert, Axel Hegele, Peter Barth, Rainer Hofmann, Axel Heidenreich.   

Abstract

INTRODUCTION: A total of 80-90% of all testicular masses are malignant germ cell tumors. Benign testicular lesions are recognized in approximately 10-20% enabling a testis-preserving surgery on the findings of frozen section examination (FSE). However, there are only sparse information with regard to the reliability of FSE in testicular tumors of uncertain dignity. Therefore, we retrospectively reviewed our experience concerning the reliability of FSE in primary testicular tumors by comparing each FSE result to the final diagnosis. PATIENTS AND METHODS: From 1974 to 2000, 354 patients were operated on a testicular tumor. During inguinal exploration and after clamping of the spermatic cord and appropriate dressing, a representative biopsy of the tumor was taken and sent for FSE. In case of malignancy radical orchiectomy was performed, in case of benign findings or in case of a germ cell tumor in a solitary testicle, the tumor was enucleated. Slides of FSE and the permanent sections were reviewed and compared with regard to the histological diagnosis and presence/absence of malignancy.
RESULTS: Based on FSE, 317 tumors (89.5%) were found to be malignant ((100 seminomas (38.5%), 217 nonseminomas (61.5%)) and 37 tumors (10.5%) were benign (17 epidermoid cysts, 14 Leydig cell tumors, two cystadenomas, two simple cysts, two hemangiomas). Comparing FSE and definitive diagnosis, FSE correctly identified all malignant and benign lesions. There was a failure rate of 10 and 8% to differentiate seminomatous from nonseminomatous tumors and vice versa based on FSE, which, however, was irrelevant for the surgical management. Complications of the enucleations (n = 37) were: testicular atrophy in three cases, testicular hematoma in three cases, orchitis/epididymitis in one case. Not a single case disclosed a local relapse after a mean follow-up of 105 (12-240) months.
CONCLUSIONS: Intraoperative FSE correctly identified all malignant and benign testicular masses including radical orchiectomy or organ-preserving surgery. Surgical management of testicular tumors based on FSE results is clinically practicable.

Entities:  

Mesh:

Year:  2002        PMID: 12180230     DOI: 10.1016/s0302-2838(02)00004-0

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  23 in total

1.  Testicular angioleiomyoma presenting with haematospermia.

Authors:  Goran Stimac; Alma Demirovic; Bozo Kruslin; Davor Tomas
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

Review 2.  [Diagnosis and primary treatment of testicular tumor].

Authors:  S Kliesch
Journal:  Urologe A       Date:  2004-12       Impact factor: 0.639

3.  Zero-ischemia testis-sparing surgery for probably benign pediatric testicular tumors.

Authors:  Silvia Ceccanti; Irene Pecorella; Amalia Schiavetti; Gianmarco Andreoli; Antonio Ciardi; Denis A Cozzi
Journal:  Pediatr Surg Int       Date:  2021-03-02       Impact factor: 1.827

4.  Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study.

Authors:  Florian Laclergerie; Guillaume Mouillet; Alexandre Frontczak; Loïc Balssa; Pascal Eschwege; Christian Saussine; Stéphane Larré; Luc Cormier; Antoine Thiery Vuillemin; François Kleinclauss
Journal:  World J Urol       Date:  2017-12-11       Impact factor: 4.226

Review 5.  Therapeutic strategies for uncommon testis cancer histologies: teratoma with malignant transformation and malignant testicular sex cord stromal tumors.

Authors:  Mounsif Azizi; Ahmet M Aydin; Salim K Cheriyan; Charles C Peyton; Matthew Montanarella; Scott M Gilbert; Wade J Sexton
Journal:  Transl Androl Urol       Date:  2020-01

Review 6.  Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia in situ.

Authors:  Pia Paffenholz; David Pfister; Axel Heidenreich
Journal:  Transl Androl Urol       Date:  2020-01

7.  The natural history of Leydig cell testicular tumours: an analysis of the National Cancer Registry.

Authors:  G J Nason; E J Redmond; S W Considine; S I Omer; D Power; P Sweeney
Journal:  Ir J Med Sci       Date:  2017-07-19       Impact factor: 1.568

Review 8.  [Importance of pathology for therapy planning of testicular germ cell tumors].

Authors:  A Heidenreich; R Knüchel-Clarke; D Pfister
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

Review 9.  Contemporary diagnostic work-up of testicular germ cell tumours.

Authors:  Klaus-Peter Dieckmann; Ulrich Frey; Guntram Lock
Journal:  Nat Rev Urol       Date:  2013-11-12       Impact factor: 14.432

10.  Organ-sparing surgery is the treatment of choice in benign testicular tumors.

Authors:  Nicolai Leonhartsberger; Renate Pichler; Brigitte Stoehr; Wolfgang Horninger; Hannes Steiner
Journal:  World J Urol       Date:  2013-10-04       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.